Scrip is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Start-up Rempex Pharmaceuticals Inc. (developing therapeutics aimed at antibiotic resistance) completed the first closing of a Series B financing that could reach $67.5mm. Participating in the round were new investors Frazier Healthcare Ventures and Vivo Ventures, along with returning shareholders SV Life Sciences, OrbiMed Advisors, and Adams Street Partners.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?